Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10164214 | 0.92 | KMT2A (0.34) | KMT2AMEN1CYP2D6TSHRALDH1A1 | |
| SCHEMBL10164295 | 0.84 | KMT2A (0.40) | KMT2AMEN1CYP2D6TSHR | |
| SCHEMBL12991169 | 0.82 | MEN1 (0.31) | KMT2AMEN1GAA | |
| SCHEMBL17281376 | 0.82 | TSHR (0.39) | KMT2AMEN1TSHRALDH1A1ESR1 | |
| SCHEMBL10201407 | 0.81 | KMT2A (0.32) | KMT2AMEN1CYP2D6 | |
| SCHEMBL10164213 | 0.81 | LMNA (0.41) | KMT2AMEN1CYP2D6 | |
| SCHEMBL10164226 | 0.81 | KMT2A (0.37) | KMT2AMEN1CYP2D6TSHRALDH1A1 | |
| SCHEMBL10164229 | 0.77 | KMT2A (0.32) | KMT2AMEN1 | |
| Bicarbonate SCHEMBL3798404 | 0.76 | KMT2A (0.34) | KMT2AMEN1TSHRALDH1A1ESR1 | |
| SCHEMBL10164356 | 0.75 | ADH1C (0.32) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120083557-A1 | STERICALLY HINDERED AMINE STABILIZERS | BASF SE (DE) | 2012-04-05 | — | — | US | disclosed |
| US-20120083557-A1 | STERICALLY HINDERED AMINE STABILIZERS | BASF SE (DE) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120083557-A1 | STERICALLY HINDERED AMINE STABILIZERS | AAAS, H1-5, H1-2 | KMT2A 211/4885MEN1 1314/4885CYP2D6 3549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.